Najat Khan

RXRX

Najat Khan serves as director, officer: CEO and President at Recursion Pharmaceuticals, Inc. (RXRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$979.7K

Net Position

Net Seller

$979.7K

Companies Traded

RXRX

Active Period

Aug 2025 – Jun 2026

5 total trades

Most Recent

Sell RXRX

Jun 5, 2026 · $84.5K

Najat Khan's Insider Trading at Recursion Pharmaceuticals, Inc. (RXRX)

Buys

0 · $0.00

Sells

5 · $979.7K

Total Shares Bought

Total Shares Sold

227,168

RXRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 5, 2026	Sell	23,588	$3.58	$84.5K	2,175,796
Mar 11, 2026	Sell	28,298	$3.35	$94.7K	2,262,085
Feb 17, 2026	Sell	14,280	$3.49	$49.8K	0
Dec 29, 2025	Sell	124,403	$4.41	$548.6K	611,135
Aug 19, 2025	Sell	36,599	$5.52	$202.2K	668,197